Abstract:Background It is unclear whether high‐sensitivity troponin T (hs‐TnT) is associated with subclinical cardiac changes in chronic kidney disease (CKD). We evaluated the relationship between hs‐TnT and left ventricular structure and function in a CKD population, according to estimated glomerular filtration rate. Methods and Results We analyzed 2017 patients with CKD stages 1 to 5 (predialysis) in the KNOW‐CKD (Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease) cohort. The predictor was hs‐TnT level measured at baseline, and the outcomes were left ventricular hypertrophy (LVH) and systolic and diastolic dysfunction shown by echocardiography at baseline and after 4 years. Participants were categorized into quartiles according to hs‐TnT levels. The associations between quartiles of hs‐TnT and outcomes were assessed using multivariable logistic regression analysis with confounders including demographics, medical history, and laboratory findings. A receiver operating characteristic curve was used to assess the diagnostic power of hs‐TnT for the outcomes as a continuous variable. For subgroup analysis, patients were stratified based on an estimated glomerular filtration rate of 60 mL/min per 1.73 m 2 . Elevated hs‐TnT was associated with LVH and diastolic dysfunction at baseline in an adjusted model but was not associated with systolic dysfunction. These associations remained significant for both estimated glomerular filtration rate subgroups. Receiver operating characteristic curve analysis showed that hs‐TnT as a continuous variable exhibited fair significance for detection of LVH (area under the curve: 0.689) and diastolic dysfunction (area under the curve: 0.744). Multivariable analysis showed that higher hs‐TnT levels at baseline were related to development of LVH but not diastolic dysfunction (n=864). Conclusions In CKD patients, hs‐TnT is strongly associated with alterations of left ventricular structure and diastolic dysfunction for both estimated glomerular filtration rate strata. Baseline hs‐TnT levels are predictive of new LVH on follow‐up. Clinical Perspective What Is New? In patients with chronic kidney disease, high‐sensitivity troponin T (TnT) is strongly associated with alterations of left ventricular structure and diastolic dysfunction, regardless of estimated glomerular filtration rate strata. Baseline levels of high‐sensitivity TnT are predictive of new left ventricular hypertrophy on follow‐up. What Are the Clinical Implications? This research suggests that a high‐sensitivity TnT assay could be a useful targeted strategy for risk stratification of patients who may need further cardiac evaluation, regardless of renal function. Further studies are needed to confirm the ideal cutoff values for high‐sensitivity TnT in chronic kidney disease. Introduction Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD). It is important to identify risk factors for prevention of cardiovascular disease in patients with CKD to facilitate treatment in the asymptomatic phase. Although pathologic changes in cardiac structure including left ventricular hypertrophy (LVH) may affect cardiovascular mortality, 1 , 2 they do not produce definite cardiac symptoms. For these reasons, physicians and researchers have invested considerable effort into identifying biomarkers related to subclinical changes in cardiac structure. The conventional cardiac troponin T (TnT) assay has become a widely used biomarker for diagnosing acute coronary syndrome. 3 Troponin assays have continued to evolve, and a high‐sensitivity TnT (hs‐TnT) assay with detection limits 10 to 100 times lower than conventional assays is now available. Importantly, hs‐TnT can be detected in asymptomatic patients with no history of cardiovascular disease. Chronically elevated levels of hs‐TnT were recently shown to be associated with chronic subclinical myocardial damage in the general population, including left ventricular (LV) structure abnormalities. 4 , 5 , <a class="tab-link" href="#jah34438-bib-000 -Abstract Truncated-

High-sensitive troponin T, suPAR and Beta-2-microglobulin changes in concentration during hemodialysis

Diagnosis of Acute Myocardial Infarction in Hemodialysis Patients with High-Sensitivity Cardiac Troponin T Assay.

The short-term prediction of high-sensitivity cardiac troponin T in patients undergoing maintenance hemodialysis

Superiority of high sensitivity cardiac troponin I over NT-proBNP and adiponectin for 7-year mortality in stable patients receiving haemodialysis

Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study

Diagnostic value of high sensitivity cardiac troponin T (hs-cTnT) in dialysis patients with myocardial infarction

Assessment of serum cardiac troponin T and C-reactive protein in predicting hemodialysis outcome

Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients

Prognostic Efficacy of Combined Index of Cardiac Biomarkers for Cardiovascular and All-Cause Mortality on Hemodialysis Patients

High-Sensitivity Cardiac Troponin T Assessment to Improve Cardiovascular Risk Prognostication in Patients with Chronic Kidney Disease: Ready for Prime Time?

Association Between High-Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW-CKD Cohort Study.

Role of Cardiac Troponins in Predicting Adverse Outcomes in Acute Coronary Syndrome With Renal Dysfunction

Superior Predictive Value for NTproBNP Compared with High Sensitivity cTnT in Dialysis Patients: A Pilot Prospective Observational Study

Multimarker Approach to Risk Stratification for Long-Term Mortality in Patients on Chronic Hemodialysis

Exploring the relation between Interleukin-6 and high-sensitive cardiac troponin T in asymptomatic hemodialysis patient: A cross-sectional study

Acute Kidney Injury and High-Sensitivity Cardiac Troponin T Levels in the Emergency Department

The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease

Differences in Cardiac Troponin T Composition in Myocardial Infarction and End-Stage Renal Disease Patients: A Blood Tube Effect?

Measures of wave intensity as a non-invasive surrogate for cardiac function predicts mortality in haemodialysis patients

ACUTE VASCULAR RESPONSE TO HEMODIALYSIS AS MEASURED BY SERUM SYNDECAN-1 AND ENDOTHELIN-1 LEVELS, AS WELL AS VASCULAR STIFFNESS

Influence factors of serum high-sensitivity cardiac troponin T among chronic kidney disease patients